Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
JCO Clinical Cancer Informatics
|
May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation
Timothy A Lin, Zachary R McCaw, Alex Koong, et al.
JAMA Oncology
|
June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.
Cancer
|
January 9, 2019
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes
Timothy A Lin, Adam S Garden, Hesham Elhalawani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute
|
July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal of Geriatric Oncology
|
November 13, 2019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials
Ethan B Ludmir, Ishwaria M Subbiah, Walker Mainwaring, et al.
Cancer Research Communications
|
August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials
Esther J Beck, Alexander D Sherry, Marcus A Florez, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
JCO Clinical Cancer Informatics
|
May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation
Timothy A Lin, Zachary R McCaw, Alex Koong, et al.
JAMA Oncology
|
June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.
Cancer
|
January 9, 2019
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes
Timothy A Lin, Adam S Garden, Hesham Elhalawani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute
|
July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal of Geriatric Oncology
|
November 13, 2019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials
Ethan B Ludmir, Ishwaria M Subbiah, Walker Mainwaring, et al.
Cancer Research Communications
|
August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials
Esther J Beck, Alexander D Sherry, Marcus A Florez, et al.
Page
of 6